Publications

5808 Results

Three cycles of CHOP (3) plus radiotherapy (RT) is superior to eight cycles of CHOP (8) alone for localized intermediate and high grade non-Hodgkin's lymphoma (NHL): A Southwest Oncology Group study.

Authors
TP Miller;S Dahlberg;JR Cassady;C Spier;TM Grogan;S Carlin;E Chase;RI Fisher
Journal / Conference
American Society of Clinical Oncology 15:411(#1257)
Year
1996
Research Committee(s)
Lymphoma
Study Number(s)
SWOG-8736 (INT-0093)

Superiority of chemo-radiotherapy (CT-RT) vs radiotherapy (RT) in patients (pts) with locally advanced nasopharyngeal cancer (NPC). Preliminary results of intergroup (0099) (SWOG8892, RTOG8817, ECOG2388) randomized study.

Authors
M Al-Sarraf;M LeBlanc;PGS Giri;K Fu;J Cooper;T Vuong;A Forastiere;G Adams;W Sakr;D Schuller;J Ensley
Journal / Conference
American Society of Clinical Oncology 15:313(#882)
Year
1996
Research Committee(s)
Head and Neck
Study Number(s)
SWOG-8892 (INT-0099) (EST-2388) (RTOG-8817)

Fluorouracil (FU), leucovorin (LV) and levamisole (LEV) adjuvant therapy for colon cancer: Preliminary results of INT-0089.

Authors
DG Haller;PJ Catalano;JS Macdonald;RJ Mayer
Journal / Conference
American Society of Clinical Oncology 15:211(#486)
Year
1996
Research Committee(s)
Gastrointestinal
Study Number(s)
SWOG-8899 (INT-0089)

AML in the elderly: Stratification by MDR1 phenotype, secondary vs de novo status, and cytogenetics identifies patients with high complete remission (CR) rates. A Southwest Oncology Group study.

Authors
CP Leith;KJ Kopecky;J Godwin;T McConnell;M Slovak;IM Chen;DR Head;F Appelbaum;CL Willman
Journal / Conference
American Society of Clinical Oncology 15:359(#1058)
Year
1996
Research Committee(s)
Leukemia
Study Number(s)
SWOG-9031

Combined hepatic chemoembolization (CE) and systemic continuous infusion 5-FU (CIFU) + leucovorin (LV) for metastatic colorectal cancer (MCC): A phase II Southwest Oncology Group trial.

Authors
CG Leichman;J Jacobson;M Zalupski;L Leong;J Benedetti
Journal / Conference
American Society of Clinical Oncology 15:215(#500)
Year
1996
Research Committee(s)
Gastrointestinal
Study Number(s)
SWOG-9051

Phase II trial of B-trans-retinoic acid (TRA) in primary hepatomas (SWOG-9157).

Authors
FL Meyskens Jr;B Nguyen;J Jacobson;J Macdonald
Journal / Conference
American Society of Clinical Oncology 15:229(#559)
Year
1996
Research Committee(s)
Gastrointestinal
Study Number(s)
SWOG-9157

Edatrexate and carboplatin in stage IV non-small cell lung cancer: Phase II trial of the Southwest Oncology Group (SWOG).

Authors
D Gandara;M Edelman;G Smith;J Crowley;R Livingston
Journal / Conference
American Society of Clinical Oncology 15:397(#1202)
Year
1996
Research Committee(s)
Lung
Study Number(s)
SWOG-9207

Phase II trial of recombinant human interleukin-4 (rhuIL-4) in patients with disseminated malignant melanoma: A Southwest Oncology Group (SWOG) study.

Authors
RP Whitehead;J Unger;SP Balcerzak;JW Goodwin;SE Rivkin;LE Flaherty;VK Sondak
Journal / Conference
American Society of Clinical Oncology 15:438(#1363)
Year
1996
Research Committee(s)
Melanoma
Study Number(s)
SWOG-9228

Phase II trial of recombinant human interleukin-4 (rhuIL-4) in patients with disseminated renal cell adenocarcinoma: A Southwest Oncology Group (SWOG) study.

Authors
RP Whitehead;B Blumenstein;RC Flanigan;GR Weiss;DJ Culkin;SI Bearman;S Dakhil;ED Crawford
Journal / Conference
American Society of Clinical Oncology 15:259(#672)
Year
1996
Research Committee(s)
Genitourinary
Study Number(s)
SWOG-9230

Phase II trial of casodex in advanced prostate cancer (CaP) patients who failed conventional hormonal manipulation: A Southwest Oncology Group (SWOG) study (SWOG9235).

Authors
O Kucuk;B Blumenstein;C Moinpour;D Lew;D Coleman;M Eisenberger;D Crawford
Journal / Conference
American Society of Clinical Oncology 15:245(#618)
Year
1996
Research Committee(s)
Genitourinary
Study Number(s)
SWOG-9235